ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
121 hedge funds and large institutions have $535M invested in Endocyte, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 35 increasing their positions, 34 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less call options, than puts
Call options by funds: $26.2M | Put options by funds: $28.4M
Holders
121
Holding in Top 10
1
Calls
$26.2M
Puts
$28.4M
Top Buyers
| 1 | +$60.9M | |
| 2 | +$16M | |
| 3 | +$14.8M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$8.83M |
| 5 |
Barclays
London,
United Kingdom
|
+$7.19M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$5.63M | |
| 3 | -$4.29M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.49M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.21M |